Organization

Cancer University Institute of Toulouse - Oncopole

2 abstracts

Abstract
Phase I/IIa study of concomitant radiotherapy with olaparib and temozolomide in unresectable high grade glioma patients: OLA-TMZ-RTE-01.
Org: Centre François Baclesse, Centre Léon Berard, Cancer University Institute of Toulouse - Oncopole, University Hospital, CHU Bordeaux, Hospices Civils de Lyon (HCL),
Abstract
Ixazomib and daratumumab without dexamethasone (I-Dara) in elderly frail patients with RRMM: Results of the multicenter phase 2 study (IFM 2018-02) of the Intergroupe Francophone du Myélome (IFM).
Org: University Hospital of Nantes, France, Centre Hospitalier Universitaire de Poitiers, CHU Grenoble Alpes, Lille University Hospital, APHP Hôpital Avicenne,